NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Longeveron Inc (NASDAQ: LGVN)

 
LGVN Technical Analysis
2.5
As on 18th May 2022 LGVN Share Price closed @ 8.39 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.44 & Strong Buy for SHORT-TERM with Stoploss of 6.84 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

LGVN Share Price

Open 8.91 Change Price %
High 9.29 1 Day -0.73 -8.00
Low 8.17 1 Week 0.42 5.27
Close 8.39 1 Month -7.22 -46.25
Volume 245900 1 Year 0.98 13.23
52 Week High 42.30 | 52 Week Low 2.92
 
NASDAQ USA Most Active Stocks
AMD 96.28 -6.04%
AAPL 140.82 -5.64%
BRQS 0.19 11.76%
SNDL 0.41 -6.82%
GNUS 0.78 13.04%
AGRI 2.92 8.96%
BBIG 3.05 6.64%
ENDP 0.62 -46.55%
NVDA 169.38 -6.82%
SOFI 7.23 2.55%
 
NASDAQ USA Top Gainers Stocks
NDRAW 0.03 200.00%
EYESW 0.48 92.00%
SMIHW 0.15 87.50%
ZJZZT 38.00 78.82%
THCAW 0.33 73.68%
WKSPW 0.63 57.50%
TMPMW 0.11 57.14%
BROGW 0.42 55.56%
PPHPR 0.14 55.56%
EFTRW 0.23 53.33%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
VENAW 0.05 -50.00%
ALACW 0.01 -50.00%
BTAQW 0.01 -50.00%
ENDP 0.62 -46.55%
MDGSW 0.21 -44.74%
ALACR 0.04 -42.86%
IKNX 19.52 -42.42%
NLITW 0.09 -40.00%
ROVRW 1.30 -34.34%
 
 
LGVN
Daily Charts
LGVN
Intraday Charts
Whats New @
Bazaartrend
LGVN
Free Analysis
 
LGVN Important Levels Intraday
RESISTANCE10.55
RESISTANCE9.86
RESISTANCE9.43
RESISTANCE9.00
SUPPORT7.78
SUPPORT7.35
SUPPORT6.92
SUPPORT6.23
 
LGVN Target for Month May
4th UP TARGET21.8
3rd UP TARGET17.5
2nd UP TARGET14.84
1st UP TARGET12.18
1st DOWN TARGET4.6
2nd DOWN TARGET1.94
3rd DOWN TARGET-0.72
4th DOWN TARGET-5.02
 
LGVN Weekly Target
4th UP TARGET14.11
3rd UP TARGET12.28
2nd UP TARGET11.14
1st UP TARGET10.01
1st DOWN TARGET6.77
2nd DOWN TARGET5.64
3rd DOWN TARGET4.50
4th DOWN TARGET2.67
 
LGVN Target for Year 2022
4th UP TARGET89.63
3rd UP TARGET63.58
2nd UP TARGET47.47
1st UP TARGET31.37
1st DOWN TARGET-14.59
2nd DOWN TARGET-30.69
3rd DOWN TARGET-46.8
4th DOWN TARGET-72.85
 
 
LGVN Other Details
Segment EQ
Market Capital 66709956.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
LGVN Address
LGVN
 
LGVN Latest News
 
Your Comments and Response on Longeveron Inc
 
LGVN Business Profile
Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications comprising aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida. Address: 1951 NW 7th Avenue, Miami, FL, United States, 33136
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service